Data / Form D filings / Vaxin Inc.
Vaxin Inc.: Form D filings
Vaxin Inc., a biotechnology company in Gaithersburg, MD, filed 2 Form D notices with the SEC in 2015. The latest, on March 24, 2015, reports $42 million sold of a $42 million offering to 60 investors.
Find out what Vaxin Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 19 FIRSTFIELD ROAD, Gaithersburg, MD, 20878
- Phone
- (240) 654-1450
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1636613
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 24, 2015 | New notice | $42,000,000 | $42,000,000 | $0 | 60 | Mar 10, 2015 | sec.gov |
| Mar 24, 2015 | New notice | $16,000,000 | $8,000,000 | $8,000,000 | 7 | Mar 10, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Philippe Pouletty | Director | |
| Scot Roberts | Executive Officer | |
| Florent Gros | Director | |
| Philip Hodges | Director | |
| Klaus Schafer | Director | |
| William Enright | Executive Officer, Director | |
| Marten Steen | Director | |
| David Drutz | Director |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Mar 23, 2015 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vaxin Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.